New PCSK9 Approval, Biosimilar Cost Tops Specialty Pharmacy Week in Review

Aug 28, 2015

By Davy James, Managing Editor

Top stories of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/pcsk9-approval-biosimilar-cost" target="_blank">View the story "New PCSK9 Approval, Biosimilar Cost Tops Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos

Related Content

Panel: Collaboration, Increased Naloxone Availability Can Help Prevent Opioid-Related Deaths

January 27th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

FDA Approves Adjuvant Pembrolizumab for Non–Small Cell Lung Cancer

January 27th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Study Finds Increased Cancer Mortality in Patients With Type 2 Diabetes

January 27th 2023

Study Illustrates Need for Timely Symptom Management to Prevent Suicide in Patients With Cancer

January 27th 2023

Panel: Collaboration, Increased Naloxone Availability Can Help Prevent Opioid-Related Deaths

January 27th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

FDA Approves Adjuvant Pembrolizumab for Non–Small Cell Lung Cancer

January 27th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Study Finds Increased Cancer Mortality in Patients With Type 2 Diabetes

January 27th 2023

Study Illustrates Need for Timely Symptom Management to Prevent Suicide in Patients With Cancer

January 27th 2023

Panel: Collaboration, Increased Naloxone Availability Can Help Prevent Opioid-Related Deaths

January 27th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

FDA Approves Adjuvant Pembrolizumab for Non–Small Cell Lung Cancer

January 27th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Study Finds Increased Cancer Mortality in Patients With Type 2 Diabetes

January 27th 2023

Study Illustrates Need for Timely Symptom Management to Prevent Suicide in Patients With Cancer

January 27th 2023

Related Content

Panel: Collaboration, Increased Naloxone Availability Can Help Prevent Opioid-Related Deaths

January 27th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

FDA Approves Adjuvant Pembrolizumab for Non–Small Cell Lung Cancer

January 27th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Study Finds Increased Cancer Mortality in Patients With Type 2 Diabetes

January 27th 2023

Study Illustrates Need for Timely Symptom Management to Prevent Suicide in Patients With Cancer

January 27th 2023

Recent Content

View More Recent Content

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.